ID   AURKA_RAT               Reviewed;         397 AA.
AC   P59241;
DT   27-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   27-JAN-2003, sequence version 1.
DT   02-OCT-2024, entry version 155.
DE   RecName: Full=Aurora kinase A {ECO:0000312|RGD:628895};
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:P04198};
DE   AltName: Full=Aurora 2 {ECO:0000250|UniProtKB:O14965};
DE   AltName: Full=Aurora/IPL1-related kinase 1 {ECO:0000250|UniProtKB:O14965};
DE            Short=ARK-1 {ECO:0000250|UniProtKB:O14965};
DE            Short=Aurora-related kinase 1 {ECO:0000250|UniProtKB:O14965};
DE   AltName: Full=Ipl1- and aurora-related kinase 1 {ECO:0000250|UniProtKB:P97477};
DE   AltName: Full=Serine/threonine-protein kinase 15 {ECO:0000250|UniProtKB:O14965};
DE   AltName: Full=Serine/threonine-protein kinase 6 {ECO:0000250|UniProtKB:O14965};
DE   AltName: Full=Serine/threonine-protein kinase Ayk1 {ECO:0000250|UniProtKB:P97477};
DE   AltName: Full=Serine/threonine-protein kinase aurora-A {ECO:0000303|PubMed:12124350};
DE            Short=ratAurA {ECO:0000303|PubMed:12124350};
GN   Name=Aurka {ECO:0000312|RGD:628895};
GN   Synonyms=Aik {ECO:0000250|UniProtKB:O14965},
GN   Airk1 {ECO:0000250|UniProtKB:O14965}, Ark1 {ECO:0000250|UniProtKB:O14965},
GN   Aura {ECO:0000250|UniProtKB:O14965}, Ayk1 {ECO:0000250|UniProtKB:P97477},
GN   Btak {ECO:0000250|UniProtKB:O14965}, Iak1 {ECO:0000250|UniProtKB:P97477},
GN   Stk15 {ECO:0000250|UniProtKB:O14965}, Stk6 {ECO:0000250|UniProtKB:O14965};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar Furth; TISSUE=Mammary gland;
RX   PubMed=12124350;
RA   Goepfert T.M., Adigun Y.E., Zhong L., Gay J., Medina D., Brinkley W.R.;
RT   "Centrosome amplification and overexpression of aurora A are early events
RT   in rat mammary carcinogenesis.";
RL   Cancer Res. 62:4115-4122(2002).
RN   [2]
RP   FUNCTION, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=19812038; DOI=10.1074/jbc.m109.055897;
RA   Khazaei M.R., Puschel A.W.;
RT   "Phosphorylation of the par polarity complex protein Par3 at serine 962 is
RT   mediated by aurora A and regulates its function in neuronal polarity.";
RL   J. Biol. Chem. 284:33571-33579(2009).
CC   -!- FUNCTION: Mitotic serine/threonine kinase that contributes to the
CC       regulation of cell cycle progression (By similarity). Associates with
CC       the centrosome and the spindle microtubules during mitosis and plays a
CC       critical role in various mitotic events including the establishment of
CC       mitotic spindle, centrosome duplication, centrosome separation as well
CC       as maturation, chromosomal alignment, spindle assembly checkpoint, and
CC       cytokinesis (By similarity). Required for normal spindle positioning
CC       during mitosis and for the localization of NUMA1 and DCTN1 to the cell
CC       cortex during metaphase (By similarity). Required for initial
CC       activation of CDK1 at centrosomes (By similarity). Phosphorylates
CC       numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B,
CC       DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3,
CC       p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity (By
CC       similarity). Required for normal axon formation (PubMed:19812038).
CC       Plays a role in microtubule remodeling during neurite extension.
CC       Important for microtubule formation and/or stabilization (By
CC       similarity). Also acts as a key regulatory component of the p53/TP53
CC       pathway, and particularly the checkpoint-response pathways critical for
CC       oncogenic transformation of cells, by phosphorylating and stabilizating
CC       p53/TP53 (By similarity). Phosphorylates its own inhibitors, the
CC       protein phosphatase type 1 (PP1) isoforms, to inhibit their activity
CC       (By similarity). Inhibits cilia outgrowth (By similarity). Required for
CC       cilia disassembly via phosphorylation of HDAC6 and subsequent
CC       deacetylation of alpha-tubulin (By similarity). Regulates protein
CC       levels of the anti-apoptosis protein BIRC5 by suppressing the
CC       expression of the SCF(FBXL7) E3 ubiquitin-protein ligase substrate
CC       adapter FBXL7 through the phosphorylation of the transcription factor
CC       FOXP1 (By similarity). {ECO:0000250|UniProtKB:A0A8I3S724,
CC       ECO:0000250|UniProtKB:O14965, ECO:0000269|PubMed:19812038}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:O14965};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:O14965};
CC   -!- ACTIVITY REGULATION: Activation of CDK1, appears to be an upstream
CC       event of AURKA activation (By similarity). Phosphatase inhibitor-2
CC       (PPP1R2) and TPX2 act also as activators (By similarity). Inactivated
CC       by the G2 checkpoint (By similarity). Inhibited by GADD45A and
CC       p53/TP53, and through dephosphorylation by protein phosphatase type 1
CC       (PP1) (By similarity). MLN8054 is also a potent and selective inhibitor
CC       (By similarity). Activated during the early phase of cilia disassembly
CC       in the presence of FBXL7 and CIMAP3 (By similarity). Inhibited by the
CC       small molecule inhibitor VX-680 (By similarity).
CC       {ECO:0000250|UniProtKB:O14965}.
CC   -!- SUBUNIT: Part of a complex composed of NEDD9, AURKA and CTTN; within
CC       the complex NEDD9 acts as a scaffold protein and is required for
CC       complex formation (By similarity). Identified in a complex with AUNIP
CC       and NIN (By similarity). Interacts with CPEB1, JTB, TACC1, TPX2,
CC       PPP2CA, as well as with the protein phosphatase type 1 (PP1) isoforms
CC       PPP1CA, PPP1CB and PPP1CC (By similarity). Interacts also with its
CC       substrates ARHGEF2, BORA, KIF2A, PARD3, and p53/TP53 (By similarity).
CC       Interaction with BORA promotes phosphorylation of PLK1 (By similarity).
CC       Interacts with FBXL7 and CIMAP3 (By similarity). Interacts with
CC       GADD45A, competing with its oligomerization (By similarity). Interacts
CC       (via C-terminus) with AUNIP (via C-terminus) (By similarity). Interacts
CC       with SIRT2 (By similarity). Interacts with FRY; this interaction
CC       facilitates AURKA-mediated PLK1 phosphorylation (By similarity).
CC       Interacts with MYCN; interaction is phospho-independent and triggers
CC       AURKA activation; AURKA competes with FBXW7 for binding to
CC       unphosphorylated MYCN but not for binding to phosphorylated MYCN (By
CC       similarity). Interacts with HNRNPU (By similarity). Interacts with AAAS
CC       (By similarity). Interacts with KLHL18 and CUL3 (By similarity).
CC       Interacts with FOXP1 (By similarity). Interacts with HDAC6; AURKA-
CC       mediated phosphorylation of HDAC6 promotes deacetylation of alpha-
CC       tubulin (By similarity). {ECO:0000250|UniProtKB:O14965,
CC       ECO:0000250|UniProtKB:P97477}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000250|UniProtKB:O14965}. Cytoplasm,
CC       cytoskeleton, spindle pole {ECO:0000250|UniProtKB:O14965}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome, centriole
CC       {ECO:0000250|UniProtKB:P97477}. Cell projection, neuron projection
CC       {ECO:0000250|UniProtKB:P97477}. Cell projection, cilium
CC       {ECO:0000250|UniProtKB:O14965}. Cytoplasm, cytoskeleton, cilium basal
CC       body {ECO:0000250|UniProtKB:P97477}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:F1PNY0}. Note=Localizes on centrosomes in
CC       interphase cells and at each spindle pole in mitosis. Associates with
CC       both the pericentriolar material (PCM) and centrioles. Detected at the
CC       neurite hillock in developing neurons. Colocalized with SIRT2 at
CC       centrosome. The localization to the spindle poles is regulated by AAAS
CC       (By similarity). {ECO:0000250|UniProtKB:O14965,
CC       ECO:0000250|UniProtKB:P97477}.
CC   -!- TISSUE SPECIFICITY: Detected in neurons in brain cortex and hippocampus
CC       (at protein level). Expressed in mammary gland and tumor.
CC       {ECO:0000269|PubMed:19812038}.
CC   -!- INDUCTION: Activated by progesterone.
CC   -!- PTM: Activated by phosphorylation at Thr-281; this brings about a
CC       change in the conformation of the activation segment (By similarity).
CC       Phosphorylation at Thr-281 varies during the cell cycle and is highest
CC       during M phase (By similarity). Autophosphorylated at Thr-281 upon TPX2
CC       binding (By similarity). Thr-281 can be phosphorylated by several
CC       kinases, including PAK and PKA (By similarity). Protein phosphatase
CC       type 1 (PP1) binds AURKA and inhibits its activity by dephosphorylating
CC       Thr-281 during mitosis (By similarity). Phosphorylation at Ser-335
CC       decreases the kinase activity (By similarity). PPP2CA controls
CC       degradation by dephosphorylating Ser-52 at the end of mitosis (By
CC       similarity). Phosphorylated in embryonic brain neurons
CC       (PubMed:19812038). {ECO:0000250|UniProtKB:O14965,
CC       ECO:0000269|PubMed:19812038}.
CC   -!- PTM: Ubiquitinated by CHFR, leading to its degradation by the
CC       proteasome (By similarity). Ubiquitinated by the anaphase-promoting
CC       complex (APC), leading to its degradation by the proteasome (By
CC       similarity). Ubiquitinated by the E3 ubiquitin-protein ligase complex
CC       SCF(FBXL7) during mitosis, leading to its degradation by the proteasome
CC       (By similarity). Ubiquitinated by the CUL3-KLHL18 ligase leading to its
CC       activation at the centrosome which is required for initiating mitotic
CC       entry (By similarity). Ubiquitination mediated by CUL3-KLHL18 ligase
CC       does not lead to its degradation by the proteasome (By similarity).
CC       {ECO:0000250|UniProtKB:O14965, ECO:0000250|UniProtKB:P97477}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. Aurora subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF537333; AAN06823.1; -; mRNA.
DR   AlphaFoldDB; P59241; -.
DR   SMR; P59241; -.
DR   STRING; 10116.ENSRNOP00000051977; -.
DR   iPTMnet; P59241; -.
DR   PhosphoSitePlus; P59241; -.
DR   PaxDb; 10116-ENSRNOP00000051977; -.
DR   AGR; RGD:628895; -.
DR   RGD; 628895; Aurka.
DR   eggNOG; KOG0580; Eukaryota.
DR   InParanoid; P59241; -.
DR   PhylomeDB; P59241; -.
DR   Reactome; R-RNO-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-RNO-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-RNO-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.
DR   Reactome; R-RNO-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-RNO-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-RNO-8854518; AURKA Activation by TPX2.
DR   Reactome; R-RNO-8854521; Interaction between PHLDA1 and AURKA.
DR   PRO; PR:P59241; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0043203; C:axon hillock; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005814; C:centriole; IEA:UniProtKB-SubCell.
DR   GO; GO:0005813; C:centrosome; IDA:RGD.
DR   GO; GO:0032133; C:chromosome passenger complex; IBA:GO_Central.
DR   GO; GO:0036064; C:ciliary basal body; ISS:UniProtKB.
DR   GO; GO:0042585; C:germinal vesicle; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0000776; C:kinetochore; IBA:GO_Central.
DR   GO; GO:0072687; C:meiotic spindle; ISO:RGD.
DR   GO; GO:0015630; C:microtubule cytoskeleton; ISO:RGD.
DR   GO; GO:0005815; C:microtubule organizing center; ISO:RGD.
DR   GO; GO:0072686; C:mitotic spindle; ISO:RGD.
DR   GO; GO:0097431; C:mitotic spindle pole; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0045120; C:pronucleus; ISO:RGD.
DR   GO; GO:0005876; C:spindle microtubule; ISO:RGD.
DR   GO; GO:0051233; C:spindle midzone; IBA:GO_Central.
DR   GO; GO:0000922; C:spindle pole; ISS:UniProtKB.
DR   GO; GO:0031616; C:spindle pole centrosome; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0035175; F:histone H3S10 kinase activity; ISO:RGD.
DR   GO; GO:0140677; F:molecular function activator activity; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0009948; P:anterior/posterior axis specification; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007098; P:centrosome cycle; ISO:RGD.
DR   GO; GO:0051642; P:centrosome localization; ISO:RGD.
DR   GO; GO:0061523; P:cilium disassembly; ISS:UniProtKB.
DR   GO; GO:0097421; P:liver regeneration; ISO:RGD.
DR   GO; GO:0051321; P:meiotic cell cycle; ISO:RGD.
DR   GO; GO:0000212; P:meiotic spindle organization; ISO:RGD.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; ISO:RGD.
DR   GO; GO:0000278; P:mitotic cell cycle; ISO:RGD.
DR   GO; GO:0007100; P:mitotic centrosome separation; ISO:RGD.
DR   GO; GO:0007052; P:mitotic spindle organization; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:1990138; P:neuron projection extension; ISO:RGD.
DR   GO; GO:0090141; P:positive regulation of mitochondrial fission; ISO:RGD.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:1900195; P:positive regulation of oocyte maturation; ISO:RGD.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0071539; P:protein localization to centrosome; ISO:RGD.
DR   GO; GO:0032465; P:regulation of cytokinesis; IBA:GO_Central.
DR   GO; GO:0031647; P:regulation of protein stability; ISO:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0009611; P:response to wounding; ISO:RGD.
DR   GO; GO:0007057; P:spindle assembly involved in female meiosis I; ISO:RGD.
DR   GO; GO:0007051; P:spindle organization; ISO:RGD.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR030616; Aur-like.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24350:SF5; AURORA KINASE A; 1.
DR   PANTHER; PTHR24350; SERINE/THREONINE-PROTEIN KINASE IAL-RELATED; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell cycle; Cell division; Cell membrane; Cell projection;
KW   Cilium; Cilium biogenesis/degradation; Cytoplasm; Cytoskeleton;
KW   Isopeptide bond; Kinase; Membrane; Microtubule; Mitosis;
KW   Nucleotide-binding; Phosphoprotein; Proto-oncogene; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN           1..397
FT                   /note="Aurora kinase A"
FT                   /id="PRO_0000086694"
FT   DOMAIN          126..376
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..118
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          273..286
FT                   /note="Activation segment"
FT                   /evidence="ECO:0000250|UniProtKB:O14965"
FT   REGION          378..397
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        30..59
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        82..107
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        381..397
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        249
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         136
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         155
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         203..206
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         253..254
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O14965"
FT   BINDING         267
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14965"
FT   MOD_RES         50
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14965"
FT   MOD_RES         280
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O14965"
FT   MOD_RES         281
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O14965"
FT   MOD_RES         335
FT                   /note="Phosphoserine; by PKA and PAK"
FT                   /evidence="ECO:0000250|UniProtKB:O14965"
FT   CROSSLNK        251
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O14965"
SQ   SEQUENCE   397 AA;  44874 MW;  95DECA2198DCED85 CRC64;
     MDRCKENCVS RPVKSTVPFG PKRVLVTEQI PSQHPGSASS GQAQRVLCPS NSQRVPPQAQ
     KPVAGQKPVL KQLPAASGPR PASRLSNPQK SEQPQPAASG NNSEKEQTSI QKTEDSKKRQ
     WTLEDFDIGR PLGKGKFGNV YLAREKQSKF ILALKVLFKV QLEKAGVEHQ LRREVEIQSH
     LRHPNILRLY GYFHDATRVY LILEYAPLGT VYRELQKLSK FDEQRTATYI TELANALSYC
     HSKRVIHRDI KPENLLLGSN GELKIADFGW SVHAPSSRRT TLCGTLDYQP PEMIEGRMHD
     EKVDLWSLGV LCYEFLVGMP PFEAHTYQET YRRISRVEFT FPDFVTEGAR DLISRLLKHN
     SSQRLTLAEV LEHPWIKANS SKPPTGHNSK EATSKSS
//
